ABOUT EUROSETS INNOVATION PRODUCTS NEWS & EVENTS CONTACTS CAREERS LOGIN InnovationNews Remowell2 Lipid Microemboli introduced into the cardiopulmonary circuit are reported to be a key mechanism involved in neurological injury. Moreover, they may also impact other organs. Remowell2 has a unique and patented technology to reduce Lipid Microemboli, among other unique features. *A.dell’Amore et al. Efficacy of a New Oxygenator-Integrated Fat and Leukocyte Removal Device. Asian Cardiovasc Thorac Ann 2010;0:1–5 DISCOVER MORE ABOUT CARDIOPULMONARY PRODUCT PORTFOLIO LIPIDS REDUCTION11 Corporate Events Innovation News Social Sustainability CONTACT US Branches Career Press Office MEDIA Videos Corporate Brochure Company Model Code of Ethics C.F./P.IVA 02005430364 – Cap.Soc. € 2.072.110 i.v – C.C.I.A.A. MO n.258632 – Reg.Soc.Trib. MO n.33834 Privacy Policy | Cookie Policy | Information on Personal Area | Legal Notices © 2020 EUROSETS All rights reserved Website by TEAM99 Web Agency Modena

ABOUT EUROSETS INNOVATION PRODUCTS NEWS & EVENTS CONTACTS CAREERS LOGIN PRODUCTS HIGHLIGHT Proud to be Italian. Proud to support Healthcare providers facing the emergency in our Country and in World every day. Watch video OUR PRODUCTS CARDIOPULMONARY ECLS WOUND & BLOOD COMPANY HIGHLIGHT CorporateNews Eurosets support the first edition of Biomedical Valley workshop Read article InnovationNews Remowell2 Read article CONTACT US Branches Career Press Office MEDIA Videos Corporate Brochure Company Model Code of Ethics C.F./P.IVA 02005430364 – Cap.Soc. € 2.072.110 i.v – C.C.I.A.A. MO n.258632 – Reg.Soc.Trib. MO n.33834 Privacy Policy | Cookie Policy | Information on Personal Area | Legal Notices © 2020 EUROSETS All rights reserved Website by TEAM99 Web Agency Modena